Contact Us

MEETING NEWS

CCSC Technology International Holdings Limited Reports Financial Results for the First Six Months of Fiscal Year 2025 Ended September 30, 2024

Jan 3, 2025

HONG KONG,Dec. 28,2024--CCSC Technology International Holdings Limited (the "Company" or "CCSC") (Nasdaq: CCTG),a Hong Kong-based company that engages in the sale,design and manufa

Dahua Technology Obtains ISO 37301 Compliance Management System Certification

Jan 3, 2025

HANGZHOU,China,Dec. 30,2024-- Dahua Technology,a world-leading video-centric AIoT solution and service provider,has officially obtained the ISO 37301:2021 Compliance Management System Certification f

Alphamab Oncology Announced Anti-HER2 Bispecific ADC JSKN003 Received Approval from CDE to Initiate a Phase III Clinical Study for Ovarian Cancer

Jan 3, 2025

SUZHOU,China,Dec. 27,2024-- Alphamab Oncology (stock code: 9966.HK) announced that anti-HER2 bispecific antibody-drug conjugate (ADC) JSKN003 has received approval from the Center for Drug Evaluation

Huadong Medicine Co., Ltd. and SynerK reached a strategic cooperation to jointly develop a novel siRNA drug SNK-2726

Jan 3, 2025

SUZHOU,China,Dec. 30,2024-- Hangzhou Sino-US Huadong Medicine Co.,Ltd. (hereinafter referred to as "Huadong Medicine"),a wholly-owned subsidiary of Huadong Medicine Co.,Ltd. (SZ.000963),and

WuXi AppTec's Commitment to Sustainability Recognized by the Dow Jones Sustainability Indices (DJSI) for the Fourth Consecutive Year

Jan 3, 2025

SHANGHAI,Dec. 30,2024--WuXi AppTec,a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life science industries,announce

President Xi leads major-country diplomacy with Chinese characteristics into a new stage of greater achievements

Jan 3, 2025

BEIJING,Dec. 30,2024-- "On the new journey,major-country diplomacy with Chinese characteristics will enter a new stage where much more can be accomplished," stated the Central Conference on

1 ... 155 156 157 158 159 160 161 ... 340